Received Sep 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
never received her second dose; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 72-year-old female patient who did not receive Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received her first dose of Shingrix on 31-MAY-2022, expiry date:10 JUL 2023 and batch number: E42J2). The patient did not receive the 2nd dose of Shingrix. The patient experienced incomplete course of vaccination (Verbatim: never received her second dose). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 25-AUG-2025 The pharmacist calling to report that a patient never receive her second dose. The reporter stated that the patient received the first dose of Shingrix at another pharmacy chain and could not supply the route or location of administration from the online records. Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination.